Tissue Therapies
HOME TECHNOLOGY INVESTORS ALLIANCES COMPANY
CONTACT


Tissue Therapies Limited is an Australian company developing biomedical technologies for wound healing, tissue repair, cell culture and other applications  


VitroGro® is a synthetic scaffold that restores cell attachment and migration, the essential elements of tissue repair and wound healing.
 

30 Sep 2011
VitroGro Sales to Start Second Quarter 2011 [PDF]

14 Jul 2011
Strong New Clinical Trial Data [PDF]

20 Dec 2010
Update on EU Clinical Trial and Commercial Negotiations [PDF]

 
 
 
- Video

Based on its VitroGro® technology, Tissue Therapies is developing more effective treatments for acute and chronic wound healing applications including chronic skin ulcers and burns.

Tissue Therapies is also proceeding with the development of other commercial applications for VitroGro® and other technologies for the treatment of psoriasis, scar prevention and treatment and potential treatments for various cancers including those of the breast, colon and prostate.


The management and technical team of Tissue Therapies are highly qualified and experienced.
Introduction
Interview with Dr. Steve Mercer CEO & Director of Tissue Therapies Ltd.

Tissue Therapies current share price is available on the ASX.

  Introduction
Interview with Prof Keith Harding acting as a principal investigator of a clinical trial of VitroGro® that is being undertaken both in Europe and Australia.
   
 

Tissue Therapies forms alliances with strategic partners worldwide

 
© 2007 TISSUE THERAPIES LTD